arginyl-glycyl-aspartic acid has been researched along with Retinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, G; Kaufman, PL; Ma, JX; Saunders, RA; Zhang, D | 1 |
| de Juan, E; Dickson, J; Hatchell, DL | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Retinal Diseases
| Article | Year |
|---|---|
Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
Topics: Angiogenesis Inhibitors; Animals; Capillaries; Cell Count; Cells, Cultured; Endothelium, Vascular; Humans; Hypoxia; Injections; Kringles; Neovascularization, Pathologic; Oligopeptides; Oxygen; Peptide Fragments; Plasminogen; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Recombinant Proteins; Reference Values; Retina; Retinal Diseases; Retinal Vessels; Vitreous Body | 2001 |
Interaction of retinal glial cells with collagen matrices: implications for pathogenesis of cell-mediated vitreous traction.
Topics: Animals; Cell Adhesion; Cells, Cultured; Collagen; Extracellular Matrix; Fibroblasts; Humans; Microscopy, Electron, Scanning; Neuroglia; Oligopeptides; Peptides; Rabbits; Retina; Retinal Diseases; Vitreous Body | 1989 |